JP2012070740A5 - - Google Patents

Download PDF

Info

Publication number
JP2012070740A5
JP2012070740A5 JP2011237542A JP2011237542A JP2012070740A5 JP 2012070740 A5 JP2012070740 A5 JP 2012070740A5 JP 2011237542 A JP2011237542 A JP 2011237542A JP 2011237542 A JP2011237542 A JP 2011237542A JP 2012070740 A5 JP2012070740 A5 JP 2012070740A5
Authority
JP
Japan
Prior art keywords
composition
medicament
sepsis
osteoarthritis
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011237542A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012070740A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012070740A publication Critical patent/JP2012070740A/ja
Publication of JP2012070740A5 publication Critical patent/JP2012070740A5/ja
Pending legal-status Critical Current

Links

JP2011237542A 2000-05-10 2011-10-28 哺乳動物レセプタータンパク質；関連する試薬および方法 Pending JP2012070740A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20342600P 2000-05-10 2000-05-10
US60/203,426 2000-05-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008104044A Division JP2008273961A (ja) 2000-05-10 2008-04-11 哺乳動物レセプタータンパク質；関連する試薬および方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014254055A Division JP2015110576A (ja) 2000-05-10 2014-12-16 哺乳動物レセプタータンパク質；関連する試薬および方法

Publications (2)

Publication Number Publication Date
JP2012070740A JP2012070740A (ja) 2012-04-12
JP2012070740A5 true JP2012070740A5 (enExample) 2012-07-12

Family

ID=22753958

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2001582389A Expired - Fee Related JP5073909B2 (ja) 2000-05-10 2001-05-10 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2008104044A Withdrawn JP2008273961A (ja) 2000-05-10 2008-04-11 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2011237542A Pending JP2012070740A (ja) 2000-05-10 2011-10-28 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2012118337A Pending JP2012187111A (ja) 2000-05-10 2012-05-24 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2014210974A Pending JP2015057396A (ja) 2000-05-10 2014-10-15 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2014254055A Withdrawn JP2015110576A (ja) 2000-05-10 2014-12-16 哺乳動物レセプタータンパク質；関連する試薬および方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2001582389A Expired - Fee Related JP5073909B2 (ja) 2000-05-10 2001-05-10 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2008104044A Withdrawn JP2008273961A (ja) 2000-05-10 2008-04-11 哺乳動物レセプタータンパク質；関連する試薬および方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2012118337A Pending JP2012187111A (ja) 2000-05-10 2012-05-24 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2014210974A Pending JP2015057396A (ja) 2000-05-10 2014-10-15 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2014254055A Withdrawn JP2015110576A (ja) 2000-05-10 2014-12-16 哺乳動物レセプタータンパク質；関連する試薬および方法

Country Status (25)

Country Link
US (7) US6756481B2 (enExample)
EP (3) EP1287130B2 (enExample)
JP (6) JP5073909B2 (enExample)
KR (1) KR100869621B1 (enExample)
CN (2) CN1575337A (enExample)
AT (1) ATE396264T1 (enExample)
AU (2) AU2001261351B2 (enExample)
CA (1) CA2408571C (enExample)
CY (1) CY1108545T1 (enExample)
CZ (1) CZ304022B6 (enExample)
DE (1) DE60134136D1 (enExample)
DK (1) DK1287130T3 (enExample)
ES (1) ES2307618T3 (enExample)
HK (1) HK1049862B (enExample)
HU (1) HUP0302339A3 (enExample)
IL (2) IL152414A0 (enExample)
MX (1) MXPA02011081A (enExample)
NO (2) NO331408B1 (enExample)
NZ (1) NZ522146A (enExample)
PL (1) PL209128B1 (enExample)
PT (1) PT1287130E (enExample)
SI (1) SI1287130T1 (enExample)
SK (1) SK287984B6 (enExample)
WO (1) WO2001085790A2 (enExample)
ZA (1) ZA200208795B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082734A1 (en) * 1999-06-01 2003-05-01 Dowling Lynette M. Mammalian receptor proteins; related reagents and methods
EP2135953B1 (en) * 1999-06-02 2014-04-23 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein, Nr. 10
ES2254224T3 (es) * 1999-09-27 2006-06-16 Chugai Seiyaku Kabushiki Kaisha Nueva proteina del receptor de hematopoyetina, nr12.
SK287984B6 (sk) * 2000-05-10 2012-08-06 Schering Corporation Substantially pure or recombinant polypeptide, nucleic acid, host cell, method for the preparation of polypeptide, binding compound, kit, composition comprising an antibody and use thereof
US7422743B2 (en) 2000-05-10 2008-09-09 Schering Corporation Mammalian receptor protein DCRS5;methods of treatment
EP1576011B1 (en) 2002-10-30 2009-08-12 Genentech, Inc. Inhibition of il-17 production
JP4902961B2 (ja) 2002-12-23 2012-03-21 シェーリング コーポレイション 哺乳動物サイトカインの用途；関連試薬
WO2004071517A2 (en) * 2003-02-06 2004-08-26 Schering Corporation Uses of il-23 related reagents
ATE440864T1 (de) * 2003-03-10 2009-09-15 Schering Corp Verwendung von il-23-antagonisten; verwandte reagenzien
JP2007515939A (ja) * 2003-05-09 2007-06-21 セントカー・インコーポレーテツド ＩＬ−２３ｐ４０特異的免疫グロブリン由来タンパク質、組成物、方法および用途
CA2556425A1 (en) * 2004-02-17 2005-09-01 Schering Corporation Methods of modulating il-23 activity; related reagents
US20050287593A1 (en) 2004-05-03 2005-12-29 Schering Corporation Use of cytokine expression to predict skin inflammation; methods of treatment
AU2005241020B2 (en) * 2004-05-03 2008-07-10 Merck Sharp & Dohme Corp. Use of IL-17 expression to predict skin inflammation; methods of treatment
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
TWI363091B (en) * 2004-12-20 2012-05-01 Schering Corp Uses of mammalian cytokine; related reagents
EP2452694B1 (en) * 2005-06-30 2018-11-14 Janssen Biotech, Inc. Anti-IL-23 antibodies, compositions, methods and uses
RS55963B1 (sr) 2005-12-29 2017-09-29 Janssen Biotech Inc Humana anti-il-23 antitela, kompozicije, metode i upotrebe
DK2047863T3 (da) 2006-06-08 2013-09-16 Chugai Pharmaceutical Co Ltd Middel til forebyggelse eller behandling af inflammatoriske sygdomme
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
NZ579251A (en) 2007-02-28 2012-06-29 Schering Corp Engineered anti-il-23r antibodies
CA2679400A1 (en) * 2007-02-28 2008-09-04 Schering Corporation Combination therapy for treatment of immune disorders
WO2009072598A1 (ja) 2007-12-05 2009-06-11 Chugai Seiyaku Kabushiki Kaisha 掻痒症治療剤
CA2721713C (en) * 2008-05-05 2019-07-09 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
US20110158992A1 (en) * 2008-08-27 2011-06-30 Schering Corporation Engineered Anti-IL-23R Antibodies
US8715657B2 (en) * 2009-04-27 2014-05-06 Novartis Ag Therapeutic antibodies binding IL12Rβ1
EP2427203B1 (en) * 2009-05-05 2018-10-17 Novimmune S.A. Anti-il-17f antibodies and use thereof
SG190006A1 (en) 2010-11-04 2013-06-28 Boehringer Ingelheim Int Anti-il-23 antibodies
CN104507497B (zh) 2012-05-03 2018-10-19 勃林格殷格翰国际有限公司 抗IL-23p19抗体
WO2016014775A1 (en) 2014-07-24 2016-01-28 Boehringer Ingelheim International Gmbh Biomarkers useful in the treatment of il-23a related diseases
AR101753A1 (es) 2014-09-03 2017-01-11 Boehringer Ingelheim Int COMPUESTO DE OBJETIVO A IL-23A Y TNF-a Y USO DEL MISMO
SG10202103879YA (en) 2015-02-04 2021-05-28 Boehringer Ingelheim Int Methods of treating inflammatory diseases
ES3064335T3 (en) 2018-03-05 2026-04-24 Janssen Biotech Inc Methods of treating crohn's disease with anti-il23 specific antibody
MX2021005905A (es) 2018-11-20 2021-06-23 Janssen Biotech Inc Metodo seguro y eficaz para tratar la psoriasis con el anticuerpo especifico anti-il-23.
TW202045544A (zh) 2019-02-22 2020-12-16 美商戊瑞治療有限公司 用於治療ＰＤ－Ｌ１陰性腫瘤之ＣＤ８０胞外結構域Ｆｃ融合蛋白
US11780911B2 (en) 2019-05-23 2023-10-10 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
TW202123965A (zh) 2019-09-09 2021-07-01 德商百靈佳殷格翰國際股份有限公司 抗-il-23p19抗體調配物
MX2022014430A (es) 2020-05-21 2023-02-22 Janssen Biotech Inc Método para tratar la enfermedad inflamatoria del intestino con una terapia de combinación de anticuerpos para il-23 y tnf alfa.

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3645090A (en) 1969-06-19 1972-02-29 Citizen Watch Co Ltd Day-date quick-adjuster for calender timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5789192A (en) 1992-12-10 1998-08-04 Schering Corporation Mammalian receptors for interleukin-10 (IL-10)
US5888774A (en) 1994-12-19 1999-03-30 Cangene Corporation Recombinant DNA molecules and expression vectors for erythropoietin
US6060284A (en) 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
JPH11273358A (ja) 1998-03-26 1999-10-08 Kawasaki Steel Corp 半導体記憶装置
MXPA01012331A (es) * 1999-06-01 2002-07-30 Schering Corp Proteinas receptoras de mamiferos, reactivos y metodos relacionados.
US20030082734A1 (en) 1999-06-01 2003-05-01 Dowling Lynette M. Mammalian receptor proteins; related reagents and methods
DE60038304T3 (de) 1999-09-09 2017-04-06 Merck Sharp & Dohme Corp. Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen
ES2254224T3 (es) 1999-09-27 2006-06-16 Chugai Seiyaku Kabushiki Kaisha Nueva proteina del receptor de hematopoyetina, nr12.
JP2008099690A (ja) 1999-09-27 2008-05-01 Chugai Pharmaceut Co Ltd 新規ヘモポエチン受容体蛋白質、ｎｒ１２
SK287984B6 (sk) * 2000-05-10 2012-08-06 Schering Corporation Substantially pure or recombinant polypeptide, nucleic acid, host cell, method for the preparation of polypeptide, binding compound, kit, composition comprising an antibody and use thereof

Similar Documents

Publication Publication Date Title
JP2012021001A5 (enExample)
JP2017079785A5 (enExample)
JP2014076062A5 (enExample)
JP2011157378A5 (enExample)
Kurschus et al. IL-17 for therapy
US20140213772A1 (en) Cross-over dual variable domain immunoglobulin constructs
JP2013107899A5 (enExample)
JP2015007098A5 (enExample)
ME00519B (me) Antitijela visokog afiniteta prema humanom il-6 receptoru
JP2011184466A5 (enExample)
JP2015525230A5 (enExample)
JP2012517818A5 (enExample)
JP2015500002A5 (enExample)
JP2012504133A5 (enExample)
JP2017029157A5 (enExample)
JP2015131795A5 (enExample)
RU2016123086A (ru) Способы и композиции для лечения болезни хантингтона
JP2012525844A5 (enExample)
RU2018111508A (ru) Анти-LAG-3 антитела
JP2016524592A5 (enExample)
JP2014519524A5 (enExample)
UA116194C2 (uk) Антитіло, яке специфічно зв'язується з людським альфа-синуклеїном
RU2016151265A (ru) Антитела, направленные на cd127
JP2010526153A5 (enExample)
JP2013127002A5 (enExample)